SCHEMBL9759874

SCHEMBL9759874

CCN(CC)C1CCc2cccc(Br)c2C1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.58
DRD3 P35462 3/20 0.58
DRD4 P21917 1/20 0.58
HTR1A P08908 3/20 0.55
HTR7 P34969 3/20 0.55
HTR1D P28221 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
TSHR P16473 1/20 0.55
HTR1B P28222 1/20 0.55
HTR2A P28223 1/20 0.55
HTR2C P28335 1/20 0.55
ADRA1A P35348 1/20 0.55
ADRA1B P35368 1/20 0.55
HTR2B P41595 1/20 0.55
HTR5A P47898 1/20 0.55
BLM P54132 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
PMP22 Q01453 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8630151 0.88 HTR1A (0.71) DRD2DRD3HTR1AHTR7HTR1D
SCHEMBL7763389 0.88 HTR1A (0.71) DRD2DRD3HTR1AHTR7HTR1D
SCHEMBL8634782 0.88 HTR1A (0.71) DRD2DRD3HTR1AHTR7HTR1D
SCHEMBL9759621 0.87 DRD2 (0.49) DRD2DRD3DRD4HTR1AHTR7
SCHEMBL14591458 0.83 DRD2 (0.59) DRD2DRD3DRD4HTR1AHTR7
SCHEMBL14591459 0.83 DRD2 (0.59) DRD2DRD3DRD4HTR1AHTR7
SCHEMBL14591336 0.83 DRD2 (0.59) DRD2DRD3DRD4HTR1AHTR7
SCHEMBL14591372 0.83 DRD2 (0.59) DRD2DRD3DRD4HTR1AHTR7
SCHEMBL5361640 0.83 CHRM3 (0.67) DRD2DRD3DRD4HTR1AHTR7
SCHEMBL6540873 0.83 CHRM3 (0.67) DRD2DRD3DRD4HTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5047422-A Treating A Disorder Of The Central Nervous System, Cardiovascular System Or Intestinal Tract BAYER AKTIENGESELLSCHAFT (DE) 1991-09-10 US disclosed
US-4968679-A DISORDERS OF CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1990-11-06 US disclosed
US-4873262-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, CARDIIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1989-10-10 US disclosed
EP-0272534-A2 8-substituted 2-aminotetralins BAYER AG (DE) 1988-06-29 EP disclosed